What is NDC 0407-0690?

0407-0690 is the product NDC for Omniscan (gadodiamide), Gadodiamide 287 mg/mL injection, listed with the FDA by GE Healthcare Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

GE Healthcare Inc., NDC labeler code 0407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Omniscan?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Omniscan NDC 0407-0690 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)0407-0690Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00407-0690Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
0407-0690-10	00407069010	10 VIAL in 1 BOX (0407-0690-10) / 10 mL in 1 VIALMarketed from Apr 19, 2002
0407-0690-15	00407069015	10 VIAL in 1 BOX (0407-0690-15) / 15 mL in 1 VIALMarketed from Apr 19, 2002
0407-0690-20	00407069020	10 VIAL in 1 BOX (0407-0690-20) / 20 mL in 1 VIALMarketed from Apr 19, 2002

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Omniscan
Generic name (nonproprietary): gadodiamide
Active ingredients: Gadodiamide — 287 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: GE Healthcare Inc.NDC labeler code 0407
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020123
Marketing start: Apr 19, 2002
Listing expires: Dec 31, 2026
Other FDA classes: Magnetic Resonance Contrast Activity (Mechanism)
Identifiers: Product ID 0407-0690_dfe2f58c-7a8f-408a-9690-6300a49eda17SPL ID dfe2f58c-7a8f-408a-9690-6300a49eda17SPL set ID 1e9a37e2-f28a-4373-bf0f-3e9b60f42d8aUNII 84F6U3J2R6
Pharmacologic class: Paramagnetic Contrast Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N400407069010 followed by a unit qualifier and the quantity

Package 00407-0690-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 18, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

OMNISCAN is a gadolinium-based contrast agent for diagnostic magnetic resonance imaging (MRI) indicated for intravenous use to: Visualize lesions with abnormal vascularity in the brain, spine, and associated tissues ( 1.1 ) Facilitate the visualization of lesions with abnormal vascularity within the thoracic, abdominal, pelvic cavities, and the retroperitoneal space ( 1.2 ) 1.1 CNS (Central Nervous System) OMNISCAN is a gadolinium-based contrast agent indicated for intravenous use in MRI to visualize lesions with abnormal vascularity (or those thought to cause abnormalities in the blood-brain barrier) in the brain (intracranial lesions), spine, and associated tissues [see Clinical Studies (1…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0407-0690

What is NDC 0407-0690?: 0407-0690 is the product NDC for Omniscan (gadodiamide), Gadodiamide 287 mg/mL injection, listed with the FDA by GE Healthcare Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Omniscan (Gadodiamide).
What is the active ingredient?: Gadodiamide.
Who is the labeler?: GE Healthcare Inc., NDC labeler code 0407. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Omniscan?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Omniscan (Gadodiamide) NDC 0407-0690